Aug 23, 2019 | MedBen Rx Alliance, Rx Costs, Savings
It makes sense that qualified hospitals can purchase drugs at prices lower than even the largest retail chain. But what if we told you that you may be eligible to reap the benefits of this as well? If you’re a hospital, local school system, university or other...
Jul 12, 2019 | Guarantees, MedBen Rx, MedBen Rx Advocate, Rebates, Rx Costs, Savings
Many employers get caught up in the promised savings offered by rebate guarantees… but little do they know this could actually be costing them money, for several reasons. The first issue with rebate guarantees is that the most significant rebates are associated with...
Apr 19, 2019 | Online Services, Reporting, Rx Costs, Rx Spending, Savings
To give employers the most accurate and up-to-date information possible, MedBen has partnered with Deerwalk, Inc. to provide an upgraded data analytics and reporting platform. The strong reporting that MedBen clients come to expect is now even stronger. With our...
Jan 16, 2019 | Average Wholesale Price, Brand Name Drugs, Discounts, Generic Drugs, MedBen Rx, Rx Costs, Rx Spending, Savings
New year, higher drug prices. According to The Wall Street Journal, a representative analysis of major pharmaceutical companies found that the prices of their brand name and generic drugs have risen by an average of 6.3% in 2019 – modest compared to previous years,...
Dec 21, 2018 | Average Wholesale Price, MedBen Rx, Pharmacy Benefits Manager (PBM), Rx Costs, Savings
Drug pricing can be a confusing business… and much of the confusion stems from a drug’s average wholesale price, or AWP. On the surface, the AWP might seem to be… well, the average wholesale price or the average price of a drug. But the price to who? As...
Nov 21, 2018 | MedBen Rx, Rebates, Rx Costs, Rx Spending, Savings, Specialty Drugs
A New York Times article examines the dramatic rise in U.S. prescription drug costs over the past two decades. American drug spending was once on par with other wealthy countries, but between 1997 and 2007 our drug spending tripled… and took off again in 2013....
